The closure of a U.S. Centers for Disease Control and Prevention laboratory because of a potentially life-threatening release of anthrax could disrupt operations at the Galveston National Laboratory, which researches some of the world's deadliest diseases. The National Laboratory on the campus of UTMB works closely with the CDC on several projects, including the study of the Crimean Congo hemorrhagic fever, lab director James LeDuc said. Those efforts and other projects are likely to be jeopardized the longer the delay in reopening the Bioterrorism Rapid Response and Advanced Technology Laboratory on the CDC Roybal Campus in Atlanta, he said. “If it goes on for any length of time, it will impact that,” LeDuc said about the Crimean Congo study.